Biktarvy, formally known as bictegravir, represents a effective single-tablet therapy for controlling HIV infection. This formula unites three crucial antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It works by blocking the HIV's ability to replicate within the body, considerably reducing the viral load. For many indi